Admelog is a rapid-acting insulin similar to Humalog, another insulin lispro 100 Units/mL, currently approved in the U.S. Source: BioSpace

In investment jargon, a "unicorn" has at least two meanings. Source: BioSpace

This year wasn't big for mergers and acquisitions in biopharma, particularly compared to 2015 and 2016. Source: BioSpace

The company is shuttering the program and focusing on other compounds in its pipeline after CRS-207 failed in studies. Source: BioSpace

The approval for EGPA is based on results from the pivotal, 52-week, Phase III MIRRA1 study, conducted as a collaboration between GSK and the NIAID, part of the US NIH.…

One of the biggest concerns has been the loss of the R&D tax credit, which incentivizes companies, including life science firms, to support research. Source: BioSpace

The ZUMA-3 study results were presented in an oral session at the Annual Meeting of the ASH in Atlanta. Source: BioSpace

The deal is expected to close in the first quarter of 2018. Source: BioSpace

Dr. Hillan will remain on, and Mr. Wise will join, the Company’s Board of Directors. Source: BioSpace

These data led to FDA Breakthrough Therapy and EMA PRIME (PRIority MEdicines) designations. Source: BioSpace